Research Topics
Species | Umberto VeronesiSummaryAffiliation: European Institute of Oncology Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Chemoprevention of breast cancer with fenretinide (4-HPR): study of long-term visual and ophthalmologic tolerabilityL Mariani
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Tumori 82:444-9. 1996..However, the pattern of occurrence over time and the underlying mechanisms of these two types of complaints seem different...
Radiation survey around a Liac mobile electron linear accelerator for intraoperative radiation therapyMario Ciocca
Unit of Medical Physics, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy
J Appl Clin Med Phys 10:2950. 2009..Our data can be useful for centers planning to implement an IORT program using a mobile linear accelerator, permitting radiation safety personnel to estimate in advance the shielding required for a particular workload...
Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 yearsAliana Guerrieri-Gonzaga
Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
Oncologist 14:201-12. 2009..We analyzed risk factors and treatment outcome in a large series of women treated at one institution...
Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcomeE Botteri
Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
Ann Oncol 20:1008-12. 2009..In the case of ipsilateral breast tumour recurrence (IBTR) after breast-conserving surgery (BCS), a second conservative surgical approach maybe considered in some motivated patients whereas in others mastectomy is unavoidable...
Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 casesUmberto Veronesi
Scientific Director European Institute of Oncology, Via G Ripamonti 435, I 20141 Milan, Italy
Eur J Cancer 45:1381-8. 2009..PREMISES: Sentinel node biopsy (SNB) in patients with breast carcinoma accurately predicts the axillary node status. However, in some 4-7% of patients with negative sentinel nodes, the remaining axillary nodes harbour cancer cells...
Conservative mastectomy: extending the idea of breast conservationUmberto Veronesi
Scientific Direction, European Institute of Oncology, Milan, Italy
Lancet Oncol 13:e311-7. 2012..A complication, however infrequent, is nipple necrosis, which can be treated successfully by local excision. Several breast reconstructive techniques are used during conservative mastectomy and aesthetic results are good in most cases...
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 casesUmberto Veronesi
Istituto Europeo di Oncologia, Division of Radiotherapy, Istituto Europeo di Oncologia, Milan, Italy
Ann Surg 242:101-6. 2005..The new mobile linear accelerators easily moved close to the operating table to allow the full-dose irradiation during surgery...
A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treatedU Veronesi
Radiotherapy Division, Istituto Europeo di Oncologia, University of Milan, Via G Ripamonti 435, 20141 Milan, Italy
Eur J Cancer 37:2178-83. 2001..However, a longer follow-up is needed for a better evaluation of the possible late side-effects...
The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large seriesU Veronesi
European Institute of Oncology, Milan, Italy
Ann Oncol 19:1553-60. 2008..We assume that this excellent result is due to radiotherapy to internal mammary nodes and we propose that exploration of internal mammary nodes should be part of the staging process of carcinomas of the medial part of the breast...
Rethinking TNM: a breast cancer classification to guide to treatment and facilitate researchUmberto Veronesi
Scientific Director European Institute of Oncology, Milan, Italy
Breast J 15:291-5. 2009....
Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomyUmberto Veronesi
Scientific Directorate, European Institute of Oncology, Milan, Italy
J Natl Cancer Inst 99:727-37. 2007..Here we present an extended follow-up of the Italian trial...
Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancerUmberto Veronesi
Department of Senology, European Institute of Oncology, Milan, Italy
N Engl J Med 347:1227-32. 2002..We conducted 20 years of follow-up of women enrolled in a randomized trial to compare the efficacy of radical (Halsted) mastectomy with that of breast-conserving surgery...
Breast conservation: current results and future perspectives at the European Institute of OncologyUmberto Veronesi
Senology Department, European Institute of Oncology, Milan, Italy
Int J Cancer 120:1381-6. 2007..There are still near horizons to reach: modern neo-adjuvant and adjuvant treatments are going quickly from the laboratory to patient's bed...
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastasesU Veronesi
Division of Senology, European Institute of Oncology, Milan, Italy
Ann Oncol 18:473-8. 2007..The aim of this study was to compare SNB and -positron emission tomography (-PET) imaging, to assess their values in detecting occult axillary metastases...
Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled studyUmberto Veronesi
Scientific Direction, European Institute of Oncology, Milan, Italy
Lancet Oncol 7:983-90. 2006..Results of our previous trial showed that SLNB accurately screens the ALN for metastasis in breast cancers of diameter 2 mm or less. We aimed to update this trial with results from longer follow-up...
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancerU Veronesi
European Institute of Oncology, Milan, Italy
Ann Oncol 17:1065-71. 2006..We conducted a long-term analysis in a subgroup of women who were regularly followed up in a single center...
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancerUmberto Veronesi
Division of Senology, European Institute of Oncology, Milan, Italy
N Engl J Med 349:546-53. 2003..Although numerous studies have shown that the status of the sentinel node is an accurate predictor of the status of the axillary nodes in breast cancer, the efficacy and safety of sentinel-node biopsy require validation...
Rethinking TNM: breast cancer TNM classification for treatment decision-making and researchUmberto Veronesi
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast 15:3-8. 2006..The significant changes we propose are:..
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgeryUmberto Veronesi
Office of the Scientific Director, Milan, Italy
Arch Surg 138:1253-6. 2003..Intraoperative RT delivered with electrons at the total isodose of 2100 rad (21 Gy) could in principle substitute the currently used radiation course of external RT after breast-conserving surgery in selected cases...
Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissectionUmberto Veronesi
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Eur J Cancer 41:231-7. 2005..The 5 year overall survival rate of the whole series was 98%. Patients with negative sentinel node biopsies not submitted to axillary dissection show during follow-up a rate of overt axillary metastases that is lower than that expected...
Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapyU Veronesi
Division of Senology, European Institute of Oncology, Via G Ripamonti 435, 20141 Milan, Italy
Ann Oncol 16:383-8. 2005..The aim of the study was to assess the role of axillary radiotherapy (RT) in reducing axillary metastases in patients with early breast cancer who did not receive axillary dissection...
Chemoprevention: from research to clinical oncologyUmberto Veronesi
European Institute of Oncology, Via G Ripamonti, 435, 20141 Milan, Italy
Eur J Cancer 41:1833-41. 2005..Combination chemoprevention and the use of agents with multiple effects are other particularly promising chemoprevention strategies...
Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trialU Veronesi
Department of Senology, European Institute of Oncology, Milano, Italy
Ann Oncol 12:997-1003. 2001..Breast-conserving surgery followed by radiotherapy is a widely accepted form of treatment in patients with breast cancer of limited extent. Many attempts have been made to identify subgroups of patients who might avoid radiotherapy...
Paradigm changes in medical scienceUmberto Veronesi
European Institute of Oncology Milan, Italy
Tumori 94:141-2. 2008
Nonpalpable breast carcinomas: long-term evaluation of 1,258 casesUmberto Veronesi
IEO European Institute of Oncology, Milan, Italy
Oncologist 15:1248-52. 2010..At present in our institution some 20% of the cases are treated when nonpalpable. The aim of the present study is to analyze the characteristics and prognosis of such tumors treated in a single institution...
Breast cancerUmberto Veronesi
European Institute of Oncology, Milan, Italy
Lancet 365:1727-41. 2005..Assessment of potential molecular targets is now important in primary diagnosis. Tyrosine-kinase inhibitors and other drugs with anti-angiogenesis properties are currently undergoing preclinical investigations...
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electronsUmberto Veronesi
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast Cancer Res Treat 124:141-51. 2010..4 and 89.7%. ELIOT appears a promising feature in early breast cancer treated with breast conserving surgery, reducing the exposure of normal tissues to radiations and shortening the radiation course from 6 weeks to one single session...
Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancerU Veronesi
Senology Department, Istituto Europeo di Oncologia, Via G Ripamonti 435, I 20141, Milan, Italy
Eur J Cancer 37:454-8. 2001..These findings provide further confirmation of the validity of SNB and prompt us to suggest that it should become the method of choice for axillary staging in small-sized breast cancer...
Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled studyUmberto Veronesi
European Institute of Oncology, Milan, Italy
Ann Surg 251:595-600. 2010..We present 10-year follow-up of our single-institute trial designed to compare outcomes in patients who received no axillary dissection if the sentinel node was negative, with patients who received complete axillary dissection...
Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancerGiovanni Paganelli
Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy
Clin Cancer Res 13:5646s-5651s. 2007..In a continuous effort to seek for anticancer treatments with minimal side effects, we aim at proving the feasibility of the Intraoperative Avidination for Radionuclide Therapy, a new procedure for partial breast irradiation...
Local therapy for breast cancer in malignant lymphoma survivorsMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast 20:S99-103. 2011..We performed a retrospective review to assess the potential of performing breast conservative surgery and intraoperative radiotherapy with electrons (ELIOT), in these patients...
Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk womenUmberto Veronesi
European Institute of Oncology, Milan, Italy
J Natl Cancer Inst 95:160-5. 2003..Such a strategy would greatly reduce the numbers of women who would need to take tamoxifen to obtain the same absolute reduction in breast cancer. These findings are exploratory and need to be confirmed in other randomized trials...
Conservative treatment of breast cancer: its evolutionAlberto Luini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 94:195-8. 2005..From an oncological perspective, outcome was found to be equally effective, and this key observation provided us with significant impetus to investigate the effects of reducing the radiotherapy field...
Sentinel lymph node biopsy is feasible even after total mastectomyMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
J Surg Oncol 95:175-9. 2007..Previous mastectomy is unanimously considered to represent an absolute technical contraindication to sentinel lymph node biopsy (SLNB)...
Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidatesOreste Gentilini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Ann Surg Oncol 19:3771-6. 2012..Mastectomy is still considered the treatment of first choice in patients with ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery (BCS) and whole-breast radiotherapy...
Positive axillary sentinel lymph node: is axillary dissection always necessary?Viviana Galimberti
Division ofSenology, European Institute of Oncology, Milan, Italy
Breast 20:S96-8. 2011..Ancillary analyses of the IBCSG 23-01 and AMAROS trials, still in follow-up, may be able to do this...
Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?Viviana Galimberti
Division of Senology, Unit of Molecular Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Breast Cancer Res Treat 131:819-25. 2012..Nevertheless, a subset of patients might be at high risk of developing overt axillary disease and efforts should be made to identify such patients by ancillary analyses of the results of ongoing or recently published clinical trials...
Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institutionMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Cancer 101:905-12. 2004..Synchronous bilateral invasive breast carcinoma (SBIBC) ranged in incidence from 0.3% to as high as 12%...
Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of OncologyViviana Galimberti
Department of Senology, European Institute of Oncology, Milan, Italy
Tumori 94:52-8. 2008..We performed a retrospective analysis of patients with 4 or more axillary nodes involved and sufficient follow-up to provide indications as to whether our current treatment is adequate...
Real-time in vivo dosimetry using micro-MOSFET detectors during intraoperative electron beam radiation therapy in early-stage breast cancerMario Ciocca
Department of Medical Physics, European Institute of Oncology, Milano, Italy
Radiother Oncol 78:213-6. 2006..In the present study, a further step was made, aiming at the improvement of the effectiveness of in vivo dosimetry, based on a real-time check of the dose...
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatmentJean Yves Petit
Division of Plastic Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res Treat 96:47-51. 2006..In fact, although removal of the NAC greatly increases the patient's sensation of mutilation, and the risk of tumor involvement of the areola is reported as a very variable percentage, NAC excision still remains the standard treatment...
Sentinel lymph node biopsy in male patients with early breast cancerOreste Gentilini
Division of Breast Surgery, European Institute of Oncology, 20141, Milan, Italy
Oncologist 12:512-5. 2007..After a median follow-up of 30 months (range, 1-63) no axillary reappearance of the disease occurred. As with women, we recommend SLNB in male patients with breast cancer and clinically negative axilla...
Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal womenGiovanni Battista Ivaldi
Department of Radiation Oncology, European Institute of Oncology, Milan, Italy
Int J Radiat Oncol Biol Phys 72:485-93. 2008..To report the acute and preliminary data on late toxicity of a pilot study of boost with electron intraoperative therapy followed by hypofractionated external beam radiotherapy (HEBRT) of the whole breast...
Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsyMattia Intra
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti, 435, 20141, Milan, Italy
Ann Surg Oncol 12:895-9. 2005..Although a previous SLNB is often considered a contraindication for a subsequent SLNB, few data support this concern...
Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 yearsMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Ann Surg 247:315-9. 2008....
A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT)Mattia Intra
Department of Breast Surgery, European Institute of Oncology, Milan, Italy
Breast Cancer Res 7:R828-32. 2005..Mastectomy is therefore recommended as the first option treatment in these women...
Breast-conserving surgery in 201 very young patients (<35 years)Oreste Gentilini
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
Breast 19:55-8. 2010..Surgical treatment of breast cancer in very young patients (<35 years) is still a matter of debate, since age is a predictive factor of local recurrence after breast conservation...
Unnecessary axillary node dissections in the sentinel lymph node eraMattia Intra
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti, 435, 20141 Milan, Italy
Eur J Cancer 43:2664-8. 2007..As the clinical indications to SNB are progressively extending to encompass most breast cancer patients with non-metastatic disease who were previously excluded, great effort should be made to avoid 'unnecessary ALNDs'...
Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 proceduresMattia Intra
Division of Breast Surgery, European Institute of Oncology, University of Milan, Milan, Italy
Surgery 140:467-71. 2006
Influence of margin status on outcomes in lobular carcinoma: experience of the European Institute of OncologyViviana Galimberti
Division of Senology, European Institute of Oncology, University of Milan, Milan, Italy
Ann Surg 253:580-4. 2011..Our aim was to evaluate the influence of margin status on outcomes with a view assessing the appropriateness of conservative surgery in this breast cancer subtype...
Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institutionGiuseppe Viale
Department of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Milan, Italy
Cancer 103:492-500. 2005....
Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinideAndrea Decensi
Division of Chemoprevention, European Institute of Oncology, Milan 20141, Italy
Clin Cancer Res 9:4722-9. 2003..We determined whether IGF-I and IGFBP-3 predict second breast cancer risk, and whether their changes during fenretinide explain observed reductions in second breast cancer in women </=50 years of age...
Long-term side effects and cosmetic outcome in a pool of breast cancer patients treated with intraoperative radiotherapy with electrons as sole treatmentMaria Cristina Leonardi
Division of Radiation Oncology, European Institute of Oncology, Milan, Italy
Tumori 98:324-30. 2012..To evaluate late toxicity and cosmetic outcome after intraoperative radiotherapy using electrons (ELIOT) as sole treatment modality in early breast cancer patients...
The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the resultsAlberto Luini
Division of Breast Surgery, University of Milan, Milan, Italy
Breast Cancer Res Treat 93:55-9. 2005..At the European Institute of Oncology we started our study on ELIOT in 1999; the first step has been a phase I-II trial to test feasibility and tolerance of ELIOT in patients candidate to breast conserving surgery...
Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institutionOreste Gentilini
Division of Senology, European Institute of Oncology, Milano, Italy
Ann Surg Oncol 18:2879-84. 2011..This study was designed to present the 5-year results of patients with multicentric breast cancer who underwent sentinel lymph node biopsy (SLNB) in a single institution...
Intraoperative radiotherapy during breast conserving surgery in patients previously treated with radiotherapy for Hodgkin's diseaseMattia Intra
Department of Breast Surgery, University of Milan, Italy
Tumori 90:13-6. 2004..Mastectomy is therefore recommended as the preferred treatment option in these women...
Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcomeOreste Gentilini
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
J Surg Oncol 94:375-9. 2006..To evaluate the ipsilateral breast tumor reappearance (IBTR) rate after breast conservative surgery (BCS) following primary chemotherapy (PC) and to assess whether positive margins affects IBTR rate and overall survival (OS)...
IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiationGiovanni Paganelli
Division of Nuclear Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast 16:17-26. 2007..7 GBq 90Y-biotin (100mCi). A further large clinical trial facing IART in combination with reduced external-beam radiotherapy is, in our opinion, fully justified...
The evolution of the conservative approach to breast cancerAlberto Luini
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
Breast 16:120-9. 2007..For this reason in our Institute we are now evaluating the feasibility of a reduction of the radiation field and the sensibility and sensitivity of new diagnostic approaches for axillary staging...
Sentinel lymph node biopsy in pregnant patients with breast cancerOreste Gentilini
Division of Senology, European Institute of Oncology, Milan, Italy
Eur J Nucl Med Mol Imaging 37:78-83. 2010..Sentinel lymph node biopsy (SLNB) is currently not recommended in pregnant patients with breast cancer due to radiation concerns...
When sentinel lymph node is intramammaryMattia Intra
Breast Surgery Department, European Institute of Oncology, Via Ripamonti 435, Milan, MI 20141, Italy
Ann Surg Oncol 15:1304-8. 2008..Little attention has been placed to the presence of intramammary sentinel lymph nodes (intraMSLNs) on preoperative lymphoscintigraphy...
Is electron beam intraoperative radiotherapy (ELIOT) safe in pregnant women with early breast cancer? In vivo dosimetry to assess fetal doseViviana Galimberti
Unit of Molecular Senology, Senology Department, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
Ann Surg Oncol 16:100-5. 2009..We conclude that studies on the use of ELIOT in pregnant women treated with conservative breast surgery are justified...
Sentinel lymph node metastasis in microinvasive breast cancerMattia Intra
Department of Surgery, Breast Unit, University of Milan School of Medicine, Milan, Italy
Ann Surg Oncol 10:1160-5. 2003..Sentinel lymph node biopsy (SLNB) may obviate the need for CAD in these patients without compromising the staging of the axilla and the important prognostic information...
Sentinel lymph node biopsy performed with local anesthesia in patients with early-stage breast carcinomaAlberto Luini
Senology Division, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Arch Surg 137:1157-60. 2002..This method represents an interesting development in breast-conserving surgery...
Intraoperative radiation therapy for breast cancer: technical notesUmberto Veronesi
Breast Department, European Institute of Oncology, Milan, Italy
Breast J 9:106-12. 2003..Here we report the two different techniques in use in these trials...
Sentinel node biopsy in elderly breast cancer patientsRoberto Gennari
Department of Surgery, European Institute of Oncology, Via Ripamonti Milano 435 20141, Italy
Surg Oncol 13:193-6. 2004..The aim of this study therefore was to assess the safety of the procedure as well as the rate of axillary recurrences after sentinel node biopsy in this older population...
Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancerMattia Intra
Breast Division, University of Milan, Italy
Arch Surg 137:737-40. 2002..In our experience, IORT for limited-stage breast carcinoma is easy to perform and only briefly prolongs the duration of the surgical procedure...
No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN)Gabriel Farante
Division of Senology, European Institute of Oncology, 20141 Milan, Italy
Eur J Cancer 46:476-8. 2010..Even if the SLNB is positive, AD should not be performed immediately but only in cases where an invasive component is found on definitive pathological examination of the DIN lesions...
Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patientsViviana Galimberti
Divisions of Senology, European Institute of Oncology, Milan, Italy
Ann Surg Oncol 9:924-8. 2002..Use of lymphoscintigraphy to visualize sentinel nodes reveals that IMNs often receive lymph from the area containing the tumor...
Axillary radiotherapy instead of axillary dissection: a randomized trial. Italian Oncological Senology GroupStefano Zurrida
Department of Senology, European Institute of Oncology, Milan, Italy
Ann Surg Oncol 9:156-60. 2002..We evaluated disease-free and overall survival in patients with early breast cancer treated by breast-conservation surgery without dissection of axillary lymph nodes, receiving or not receiving axillary radiotherapy (RT)...
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trialAndrea Decensi
Divisions of Chemoprevention, European Institute of Oncology, Milan, Italy
Circulation 111:650-6. 2005..Atherosclerosis may induce VTE, or the 2 conditions may share common risk factors. We assessed the effect of tamoxifen on VTE in a breast cancer prevention trial and studied its association with risk factors for VTE...
Full-dose intraoperative radiotherapy with electrons in breast surgery: broadening the indicationsMattia Intra
Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Arch Surg 140:936-9. 2005....
[Intraoperative radiotherapy (IORT) in treatment of breast carcinoma--a new therapeutic alternative within the scope of breast-saving therapy? Current status and future prospects. Report of experiences from the European Institute of Oncology (EIO), MailanW Gatzemeier
Division of Senology, European Institute of Oncology, Milan, Italy
Strahlenther Onkol 177:330-7. 2001..In published series it has been demonstrated that the external boost can be replaced by intraoperative radiotherapy (IORT) where irradiation at a single dose from 10 up to 15 Gy was safely delivered directly to the tumor bed...
Prognosis based on primary breast carcinoma instead of pathological nodal statusS Menard
Department of Experimental Oncology E, Istituto Nazionale Tumori, Milan, Italy
Br J Cancer 70:709-12. 1994..Our data suggest that the primary tumour score provides more reliable prognostic information than pathological nodal status, and that axillary dissection can be avoided in a large number of patients...
Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic featuresS Menard
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Br J Cancer 69:1126-9. 1994..Thus, the presence of immunoreactive cells in bone marrow correlates with the expression in the primary tumour of a marker of the metastatic potential of the tumour, the 67 kDa laminin receptor...
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large seriesU Veronesi
Senology Division, Istituto Europeo di Oncologia, Milan, Italy
J Natl Cancer Inst 91:368-73. 1999....
Intraoperative radiotherapy: the debate continuesMattia Intra
Division of Breast Surgery, European Institute of Oncology, Milan, Italy
Lancet Oncol 5:340. 2004
Prognostic factors for metachronous contralateral breast cancer: a comparison of the linear Cox regression model and its artificial neural network extensionL Mariani
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Breast Cancer Res Treat 44:167-78. 1997..Research for better prognostic variables should therefore continue...
Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long-term resultsFausto Chiesa
Head and Neck Division, European Institute of Oncology, Milan, Italy
Int J Cancer 115:625-9. 2005..The trial had to be stopped prematurely for very low recruitment and had insufficient power to reveal any protective effect against oral carcinoma; nevertheless, continuing studies on this promising chemopreventive are justified...
Intraoperative electronsRoberto Orecchia
Department of Radiation Oncology, European Institute of Oncology, University of Milan, Italy
Semin Radiat Oncol 15:76-83. 2005..In our opinion, ELIOT may be an excellent alternative to EBRT for the treatment of patients with early-stage breast cancer. However, intensive long-term follow-up is needed to fully evaluate local control and possible side effects...
Synthetic retinoid fenretinide in breast cancer chemopreventionBernardo Bonanni
Division of Cancer Prevention and Genetics, European Institute of Oncology, Milano, Italy
Expert Rev Anticancer Ther 7:423-32. 2007..This review will highlight the role of fenretinide in breast cancer chemoprevention...
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkersAndrea Decensi
Division of Chemoprevention, European Institute of Oncology, and University of Milan School of Medicine, Milan, Italy
J Natl Cancer Inst 95:779-90. 2003....
Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breastMattia Intra
Department of Breast Surgery, European Institute of Oncology, Milan, Italy
Arch Surg 138:309-13. 2003....
Effect of fenretinide on ovarian carcinoma occurrenceGiuseppe De Palo
Unit of Preventive Medicine and Cancer Family Clinic, Istituto Nazionale Tumori, Milan, Italy
Gynecol Oncol 86:24-7. 2002..Furthermore, a possible protective effect of fenretinide in BRCA-mutated women was suggested. Further studies on fenretinide for the prevention of ovarian carcinoma particularly in women with genetic susceptibility appear necessary...
The nipple-sparing mastectomy: early results of a feasibility study of a new application of perioperative radiotherapy (ELIOT) in the treatment of breast cancer when mastectomy is indicatedJean Yves Petit
Plastic Surgery Division, European Institute of Oncology, Milan, Italy
Tumori 89:288-91. 2003..The nipple-sparing mastectomy is performed leaving 5 mm of glandular tissue behind the nipple areola complex to preserve its blood supply. The reconstruction is immediately performed with a prosthesis or an autologous flap...
High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locationsFranco Orsi
Interventional Radiology Unit, European Institute of Oncology, 435 Via Ripamonti, 20141 Milan, Italy
AJR Am J Roentgenol 195:W245-52. 2010..The aim of this study was to evaluate the safety and efficacy of ultrasound-guided high-intensity focused ultrasound therapeutic ablation of solid tumors in difficult locations...
Male breast cancer: a special therapeutic problem. Anything new? (Review)Roberto Gennari
Department of Surgery, European Institute of Oncology, 20141 Milano, Italy
Int J Oncol 24:663-70. 2004....
Innovation in care and research: meeting highlights from the seventh Milan Breast Cancer Conference (Milan, 15-17 June, 2005)Saverio Cinieri
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast 15:232-45. 2006..This meeting report summarizes the highlights of the 12 sessions...
Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinomaG Viale
Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan School of Medicine, Milan, Italy
Cancer 92:1378-84. 2001....
Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissectionU Veronesi
Senology Department, Istituto Europeo di Oncologia, Via G Ripamonti 435, 20141 Milano, Italy
World J Surg 25:806-8. 2001..Immunocytochemical staining for cytokeratins or other epithelial markers may be helpful for reducing the risk of missing micrometastatic foci...
Nipple-sparing mastectomy: risk of nipple-areolar recurrences in a series of 579 casesJ Y Petit
Department of Plastic Surgery, European Institute of Oncology, Via Ripamonti 435, Milan, 20 141, Italy
Breast Cancer Res Treat 114:97-101. 2009..The risk of local recurrence behind the nipple areolar complex (NAC) is the main limiting factor of the NSM procedure. To minimize such risk, we proposed in 2002 a intraoperative radiotherapy of the preserved NAC...
Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO)J Y Petit
Plastic Surgery Department, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
Breast Cancer Res Treat 117:333-8. 2009..Overall, 36 cases of metastases and 4 deaths were observed. No significant outcome difference was observed between the 800 patients receiving intraoperative radiotherapy (ELIOT) and the 201 patients receiving delayed irradiation...
Chemoprevention of breast cancer: the Italian experienceA Decensi
Chemoprevention Unit, European Institute of Oncology, Milan, Italy
J Cell Biochem Suppl 34:84-96. 2000..Moreover, updated results of the secondary prevention trial of 4-H PR and of the primary prevention trial of tamoxifen are presented. Finally, the rationale for a reduction of tamoxifen dose in future prevention trials is provided...
Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrualG De Palo
Istituto Nazionale Tumori, University of Milan, Italy
Tumori 83:884-94. 1997..This paper describes the rationale, design, methodology, organization, data management, statistics and accrual of the participating population...
Biologic activity of tamoxifen at low doses in healthy womenA Decensi
Chemoprevention Unit, European Institute of Oncology, Milan, Italy
J Natl Cancer Inst 90:1461-7. 1998..Since these adverse effects may be dose related, we investigated the effect of tamoxifen on several biomarkers when the drug was given at doses lower than those currently in use...
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)F Nole
Division of Medical Oncology, European Institute of Oncology, Milan, Italy
Ann Oncol 10:993-6. 1999....
The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trialU Veronesi
European Institute of Oncology, Milan, Italy
Eur J Cancer 35:1320-5. 1999..The prognostic value of internal mammary node status is, however, high and a biopsy on a selected lymph node should be considered for staging purposes...
Analysis of local and regional recurrences in breast cancer after conservative surgeryE Botteri
Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
Ann Oncol 21:723-8. 2010..A minority of patients treated conservatively for breast cancer will develop local or regional recurrences. Our aim was to determine how their occurrence may be linked to the evolution of the disease...
Sentinel node localization in primary melanoma: learning curve and resultsA Testori
Division of Surgical Oncology, European Institute of Oncology, Milan, Italy
Melanoma Res 9:587-93. 1999..In conclusion, SN biopsy should be performed by surgeons and nuclear medicine doctors in co-operation, both methods being adopted simultaneously to reduce the percentage of procedure failures...
When mastectomy becomes inevitable: the nipple-sparing approachJ Y Petit
Plastic Surgery Department, European Institute of Oncology, Via Ripamonti 435, 20 141 Milan, Italy
Breast 14:527-31. 2005..Two local recurrences occurred outside the radiated field. Overall, we observed three metastases and no deaths. Sixty-eight of the patients were satisfied with their reconstructed breast and 85.5% were satisfied having preserved the NAC...
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upM Colleoni
Department of Medicine, Research Unit in Medical Senology, European Institute of Oncology, Milan, Italy
Ann Oncol 20:1344-51. 2009..The role of adjuvant dose-intensive chemotherapy and its efficacy according to baseline features has not yet been established...
